Jan 8 (Reuters) - Retrophin Inc:
* RETROPHIN PROVIDES CORPORATE UPDATE AND 2018 OUTLOOK * ‍FOR FISCAL YEAR 2017, COMPANY EXPECTS TOTAL NET PRODUCT SALES OF APPROXIMATELY $155 MILLION​
* ‍COMPANY EXPECTS NET PRODUCT SALES FOR Q4 OF 2017 TO BE APPROXIMATELY $42 MILLION​
* ‍COMPANY EXPECTS A NEW DRUG APPLICATION FILING IN 2018 FOR ITS NEW FORMULATION OF THIOLA FOR TREATMENT OF CYSTINURIA Source text for Eikon: Further company coverage:
 